Featured
Innate Pharma forges ahead with lacutamab trial post-FDA investigation
Innate Pharma announced the removal of a partial clinical hold on its development programme of lacutamab, as per a 4…
CTO Europe 2023: A snapshot of challenges and opportunities in oncology
Global developments and old challenges clash with the arrival of new technologies for drug development in oncology, creating both opportunities…
Pharma’s engagement with healthcare providers has slipped in recent years
In recent years there has been a downward trend in health care provider (HCP) contact in the pharmaceutical industry with…
CTO Europe 2023: Fostering diverse oncology trials remains a challenge
Lacking diversity in clinical trials remains a challenge as 73% of global study participants are white, based on data presented…
CTO Europe 2023: Reflections on drug development through the phases
Precision medicine oncology trial designs improve the likelihood of a drug’s approval by 38%, based on a presentation held by…